Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories non-GAAP Adjusted Diluted Earnings Per Share ($/share) ($)
Form 8-K Quarterly Earnings Releases (Non-GAAP Reconciliation Tables)
Latest, FY2025
5.15
Period ended Dec 31, 2025
Change on a year earlier
+10.3%
4.67 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Diluted Earnings Per Share ($/share) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.15 | +10.3% | SEC Filing (0001628280-26-002982) ↗ |
| FY2024 | Dec 31, 2024 | 4.67 | +5.2% | SEC Filing (0001628280-26-002982) ↗ |
| FY2023 | Dec 31, 2023 | 4.44 | -16.9% | SEC Filing (0001628280-25-002092) ↗ |
| FY2022 | Dec 31, 2022 | 5.34 | +2.5% | SEC Filing (0001628280-24-002009) ↗ |
| FY2021 | Dec 31, 2021 | 5.21 | +42.7% | SEC Filing (0001628280-23-001516) ↗ |
| FY2020 | Dec 31, 2020 | 3.65 | – | SEC Filing (0001308179-25-000134) ↗ |
Breakdown
What makes up non-gaap adjusted diluted earnings per share ($/share)
Cite this data
StockData. (2026). Abbott Laboratories Non-GAAP Adjusted Diluted Earnings Per Share ($/share) ($), annual FY2020–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ng-eps-diluted
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.